Search Hotels in Sausalito

This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026 ↗

December 19, 2025

This top-shelf exchange-traded fund (ETF) checks all the right boxes for income- and value-seeking investors.

Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗

Topics Artificial Intelligence ETFs Economy

December 17, 2025

The potential agreements would mark another step in Washington’s broader effort to reshape drug pricing.

Via Stocktwits

Topics Government World Trade

Investors Rotate Out of Big Tech and AI: A Market Reassessment Underway

December 17, 2025

As late 2025 draws to a close, a significant recalibration is underway in global financial markets, with investors increasingly rotating capital away from the once-dominant Big Tech and Artificial...

Each company has a bullish case, but three stand out as great long-term buys.

Topics Artificial Intelligence Economy Stocks

Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026? ↗

December 16, 2025

“Buying the Dip” in 2025: A Strategy Rewarded, But Future Requires Caution and Diversification

Topics Bonds Economy Intellectual Property

December 16, 2025

December 16, 2025 – The "buying the dip" investment strategy, which involves purchasing an asset after its price has declined with the anticipation of a subsequent recovery, has seen significant...

7 Dividend ETFs to Buy With $2,000 and Hold Forever -- Including the Schwab U.S. Dividend Equity ETF (SCHD) ↗

Topics Artificial Intelligence Economy

3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most ↗

December 16, 2025

Via MarketBeat

December 15, 2025

It's hard to beat dividend-paying stocks -- in part because they tend to increase their payouts regularly.

The Dow Jones (^DJI) is made up of 30 of the most established and influential companies in the market. But even blue-chip stocks can struggle - some are dealing with slowing growth, outdated business...

Topics ETFs

1 Dow Jones Stock Worth Your Attention and 2 We Brush Off

December 14, 2025

These dividend growth machines could have considerable upside for long-term investors.

Topics Stocks

2 Dividend Stocks to Double Up on Right Now ↗

December 14, 2025

The American labor market is experiencing a fascinating dichotomy as it navigates late 2024 and 2025. While overall job creation has shown signs of moderation and significant revisions to earlier...

Topics Economy Intellectual Property

Manufacturing Renaissance Fuels Job Market Amidst Shifting Sands

December 09, 2025

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Topics Artificial Intelligence Economy Electric Vehicles

2 Momentum Stocks for Long-Term Investors and 1 We Brush Off

December 07, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session.

Gapping S&P500 stocks in Friday's session ↗

December 05, 2025

Via Chartmill

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

December 04, 2025

Via Investor Brand Network

Topics Government

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

December 04, 2025

From BioMedWire

Via GlobeNewswire

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗

December 04, 2025

These ETFs can provide me with lots of passive income.

Shares crashed Tuesday on what one analyst called an "overreaction" to the company's prostate cancer treatment update.

Topics ETFs Stocks

Janux Therapeutics Craters 50% On Prostate Cancer Update; Is It An 'Overreaction'? ↗

December 02, 2025

Via Investor's Business Daily

2 Dividend Stocks to Double Up On Right Now ↗

December 01, 2025

Investors don't have to worry about dividend cuts with these two stocks.

The comeback may have begun.

Topics World Trade

5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗

December 01, 2025

Via MarketBeat

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day? ↗

November 30, 2025

The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing...

1 Nasdaq 100 Stock Worth Your Attention and 2 We Brush Off

November 25, 2025

The Dow Jones Industrial Average has been on a roller-coaster ride in November 2025, experiencing significant volatility and sending mixed signals across various sectors. While the index achieved a...

Dow Jones Navigates Volatility Amidst AI Bubble Fears and Shifting Fed Expectations

November 25, 2025

The Dow Jones Industrial Average (DJIA) has recently been a barometer of a market caught between conflicting forces, demonstrating significant daily fluctuations throughout November 2025. While the...

Topics Artificial Intelligence Bonds Economy

Dow Jones Navigates Choppy Waters: Rate Cut Hopes Clash with Valuation Fears

November 24, 2025

Q3 Earnings Outperformers: BioMarin Pharmaceutical (NASDAQ:BMRN) And The Rest Of The Therapeutics Stocks

Topics Artificial Intelligence Economy Stocks

November 23, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q3, starting with BioMarin...

FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for advanced lung cancer.

Topics Artificial Intelligence

FDA Signs Off On Bayer's New Lung Cancer Drug — Early Results Look Promising ↗

November 20, 2025

Via Benzinga

Which S&P500 stocks are moving before the opening bell on Thursday? ↗

November 20, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment

November 18, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers.

Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday? ↗

Topics Artificial Intelligence

November 18, 2025

Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New York, extending its month-to-date slide to more than 5%.

Via Benzinga

Check Out What Whales Are Doing With AMGN ↗

November 18, 2025

Via Benzinga

November 17, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...